Zobrazeno 1 - 3
of 3
pro vyhledávání: '"high risk oral cavity cancer"'
Autor:
Arslan Babar, Neil M. Woody, Ahmed I. Ghanem, Jillian Tsai, Neal E. Dunlap, Matthew Schymick, Howard Y. Liu, Brian B. Burkey, Eric D. Lamarre, Jamie A. Ku, Joseph Scharpf, Brandon L. Prendes, Nikhil P. Joshi, Jimmy J. Caudell, Farzan Siddiqui, Sandro V. Porceddu, Nancy Lee, Larisa Schwartzman, Shlomo A. Koyfman, David J. Adelstein, Jessica L. Geiger
Publikováno v:
Current Oncology, Vol 28, Iss 4, Pp 2409-2419 (2021)
Adjuvant chemoradiation (CRT), with high-dose cisplatin remains standard treatment for oral cavity squamous cell carcinoma (OCSCC) with high-risk pathologic features. We evaluated outcomes associated with different cisplatin dosing and schedules, con
Externí odkaz:
https://doaj.org/article/6936c992016a4b2ca14823b8e16083d3
Autor:
Eric Lamarre, Howard Liu, Matthew Schymick, Farzan Siddiqui, Sandro V. Porceddu, Jimmy J. Caudell, Shlomo A. Koyfman, Ahmed I Ghanem, Nikhil P. Joshi, Jamie A. Ku, David J. Adelstein, Joseph Scharpf, Neal Dunlap, Brian B. Burkey, Nancy Y. Lee, Jillian Tsai, Neil M. Woody, Brandon Prendes, L. Schwartzman, Arslan Babar, Jessica L. Geiger
Publikováno v:
Current Oncology, Vol 28, Iss 221, Pp 2409-2419 (2021)
Current Oncology
Volume 28
Issue 4
Pages 221-2419
Current Oncology
Volume 28
Issue 4
Pages 221-2419
Adjuvant chemoradiation (CRT), with high-dose cisplatin remains standard treatment for oral cavity squamous cell carcinoma (OCSCC) with high-risk pathologic features. We evaluated outcomes associated with different cisplatin dosing and schedules, con
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5e46a3c7684672067b9db320c97cf398
https://www.mdpi.com/1718-7729/28/4/221
https://www.mdpi.com/1718-7729/28/4/221
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.